Cancer cells can revert to a pre-differentiated, stem-cell-like phenotype, allowing uninhibited cellular division and other metabolic adaptations that enable survival in adverse conditions.
While there are multiple signaling pathways involved in these changes, two key components enable replicative immortality, Hippo and WNT. There are multiple pathways involved in this characteristic of cancer cells. Below, we'll focus on two of these key pathways: Hippo signaling and Wnt signaling.
The Wnt/β-Catenin pathway is another evolutionarily conserved mechanism that contributed to cancer's ability to replicate indefinitely. This pathway regulates stem cell pluripotency and cell fate decisions during development. Wnt signaling has also been shown to promote nuclear accumulation of transcriptional regulators implicated in cancer, such as TAZ. Key regulators include:
Learn more about the pathways and proteins involved in Enabling Replicative Immortality:
Check out The Researcher's Guide to the Hallmarks of Cancer Research Targets:
The Hallmarks of Cancer are seminal manuscripts by Doctors Robert Weinberg and Douglas Hanahan and were published in Cell1. The authors proposed the idea that the complexity of cancer can be broken down into smaller subsets of underlying principles. The information here pertains to one Hallmark of Cancer, known as "Enabling Replicative Immortality." Other entries in this series explore the other proposed Hallmarks.
Read the additional blog posts in the Hallmarks of Cancer series to learn more:
18-CEL-47955